DV
Dividend Vision

INBP — Integrated Biopharma Inc

Integrated Biopharma Inc (INBP)

Total return is -97.9% over the past 29.8 years, 1843.7 points behind SPY at 1745.8%. Its deepest 1-year drawdown was 60.5%.

INBP is a healthcare equity fund that provides exposure to the biopharma sector through individual stock holdings. The fund does not currently offer a meaningful dividend distribution rate, making it better suited for investors seeking capital appreciation rather than regular income. With limited available data on expense ratio and fund size, investors should review the fund's prospectus for complete operational details before making allocation decisions.

INBP key facts

Asset type
Stock
Asset class
Equity
Inception date
10/30/1996
Last close
$0.17
Market cap
$5,280,134
Average volume
11030.0
Ex-dividend date
08/19/2008
Beta
0.377
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.05